Zyprexa
-
Feature Stories / Consumer issues / Business & Money / Health & Fitness
Life after Zyprexa: the Future of Eli Lilly and Company
The Indianapolis pharmaceutical company targets age-related ailments as U.S. patents on some of its most profitable drugs expire.
-
Health & Fitness / Consumer issues / Business & Money
Side Effects
The costly success of Zyprexa, Eli Lilly and Company’s top-selling antipsychotic drug.
Our Latest Stories
Upcoming Events
Most Read
Events
Recommended
Loading, please wait...